ID: ALA5086479

Max Phase: Preclinical

Molecular Formula: C198H320N44O64S

Molecular Weight: 4373.05

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(C)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC

Standard InChI:  InChI=1S/C198H320N44O64S/c1-27-105(20)159(195(303)222-120(49-37-42-79-203)168(276)210-119(48-36-41-78-202)170(278)225-132(83-99(8)9)181(289)218-124(61-69-150(255)256)172(280)215-128(65-73-154(263)264)176(284)237-145(96-244)193(301)231-139(90-113-52-56-115(248)57-53-113)190(298)241-161(107(22)29-3)197(305)236-143(94-157(269)270)189(297)228-133(84-100(10)11)179(287)212-117(46-34-39-76-200)167(275)214-126(63-71-152(259)260)174(282)223-130(163(206)271)81-97(4)5)239-164(272)108(23)207-165(273)122(59-67-148(251)252)213-171(279)123(60-68-149(253)254)217-180(288)131(82-98(6)7)224-169(277)118(47-35-40-77-201)209-166(274)116(45-33-38-75-199)211-177(285)129(74-80-307-26)221-173(281)125(62-70-151(257)258)220-185(293)137(89-112-50-54-114(247)55-51-112)230-175(283)127(64-72-153(261)262)219-182(290)134(85-101(12)13)227-188(296)142(93-156(267)268)233-183(291)135(86-102(14)15)226-186(294)138(88-111-43-31-30-32-44-111)234-198(306)162(109(24)245)242-194(302)158(104(18)19)238-191(299)140(91-147(205)250)235-196(304)160(106(21)28-2)240-178(286)121(58-66-146(204)249)216-187(295)141(92-155(265)266)232-184(292)136(87-103(16)17)229-192(300)144(95-243)208-110(25)246/h30-32,43-44,50-57,97-109,116-145,158-162,243-245,247-248H,27-29,33-42,45-49,58-96,199-203H2,1-26H3,(H2,204,249)(H2,205,250)(H2,206,271)(H,207,273)(H,208,246)(H,209,274)(H,210,276)(H,211,285)(H,212,287)(H,213,279)(H,214,275)(H,215,280)(H,216,295)(H,217,288)(H,218,289)(H,219,290)(H,220,293)(H,221,281)(H,222,303)(H,223,282)(H,224,277)(H,225,278)(H,226,294)(H,227,296)(H,228,297)(H,229,300)(H,230,283)(H,231,301)(H,232,292)(H,233,291)(H,234,306)(H,235,304)(H,236,305)(H,237,284)(H,238,299)(H,239,272)(H,240,286)(H,241,298)(H,242,302)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H,261,262)(H,263,264)(H,265,266)(H,267,268)(H,269,270)/t105-,106-,107-,108-,109+,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,158-,159-,160-,161-,162-/m0/s1

Standard InChI Key:  AQILHVQILYYCQU-VGVIKROSSA-N

Associated Targets(Human)

RD 1212 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 38078 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human coronavirus OC43 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 4373.05Molecular Weight (Monoisotopic): 4370.2859AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Xia S, Wang X, Li Y, Wang H, Xiang R, Jiang Q, Lan Q, Liang R, Li Q, Huo S, Lu L, Wang Q, Yu F, Liu K, Jiang S..  (2022)  Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus Infection.,  65  (4.0): [PMID:33929200] [10.1021/acs.jmedchem.1c00258]

Source